Jaya Chakravarty

5.9k total citations · 1 hit paper
101 papers, 4.1k citations indexed

About

Jaya Chakravarty is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Infectious Diseases. According to data from OpenAlex, Jaya Chakravarty has authored 101 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Public Health, Environmental and Occupational Health, 46 papers in Epidemiology and 22 papers in Infectious Diseases. Recurrent topics in Jaya Chakravarty's work include Research on Leishmaniasis Studies (61 papers), Trypanosoma species research and implications (29 papers) and HIV/AIDS Research and Interventions (12 papers). Jaya Chakravarty is often cited by papers focused on Research on Leishmaniasis Studies (61 papers), Trypanosoma species research and implications (29 papers) and HIV/AIDS Research and Interventions (12 papers). Jaya Chakravarty collaborates with scholars based in India, United States and United Kingdom. Jaya Chakravarty's co-authors include Shyam Sundar, Madhukar Rai, Dipti Agarwal, Henry W. Murray, Madhukar Rai, Om Prakash Singh, Anup Singh, Neha Agrawal, Shyam Sundar and Bhawana Singh and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Jaya Chakravarty

92 papers receiving 4.0k citations

Hit Papers

Antimony Toxicity 2010 2026 2015 2020 2010 100 200 300 400

Peers

Jaya Chakravarty
Jaya Chakravarty
Citations per year, relative to Jaya Chakravarty Jaya Chakravarty (= 1×) peers Alexis Nzila

Countries citing papers authored by Jaya Chakravarty

Since Specialization
Citations

This map shows the geographic impact of Jaya Chakravarty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaya Chakravarty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaya Chakravarty more than expected).

Fields of papers citing papers by Jaya Chakravarty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaya Chakravarty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaya Chakravarty. The network helps show where Jaya Chakravarty may publish in the future.

Co-authorship network of co-authors of Jaya Chakravarty

This figure shows the co-authorship network connecting the top 25 collaborators of Jaya Chakravarty. A scholar is included among the top collaborators of Jaya Chakravarty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaya Chakravarty. Jaya Chakravarty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sundar, Shyam & Jaya Chakravarty. (2024). Recent Advances in the Treatment of Leishmaniasis. The Pediatric Infectious Disease Journal. 43(9). e310–e313.
2.
Singh, Abhishek Kumar, Tanyth de Gooyer, Om Prakash Singh, et al.. (2023). Wuchereria bancrofti infection is associated with progression to clinical visceral leishmaniasis in VL- endemic areas in Muzaffarpur, Bihar, India. PLoS neglected tropical diseases. 17(10). e0011729–e0011729. 2 indexed citations
3.
Kumar, Ishan, et al.. (2022). Magnetic resonance imaging spectrum of COVID-associated rhino-orbital-cerebral mucormycosis and assessment of anatomical severity. The Neuroradiology Journal. 36(4). 404–413. 2 indexed citations
4.
Rai, Madhukar, et al.. (2021). An unusual cause of pancytopenia. National Journal of Physiology Pharmacy and Pharmacology. 11(9). 1–1.
5.
Chakravarty, Jaya, et al.. (2020). Blue nails in chronic myeloid leukemia - Is it usual?. National Journal of Physiology Pharmacy and Pharmacology. 1–1. 1 indexed citations
6.
Singh, T. N., Michaela Fakiola, Joyce Oommen, et al.. (2018). Epitope-Binding Characteristics for Risk versus Protective DRB1 Alleles for Visceral Leishmaniasis. The Journal of Immunology. 200(8). 2727–2737. 16 indexed citations
7.
Chakravarty, Jaya, et al.. (2017). A study to assess the etiology and clinical profile of patients with hyponatremia at a tertiary care hospital. National Journal of Physiology Pharmacy and Pharmacology. 1–1. 1 indexed citations
8.
Sundar, Shyam, Anup Singh, Jaya Chakravarty, & Madhukar Rai. (2015). Efficacy and Safety of Miltefosine in Treatment of Post‐Kala‐Azar Dermal Leishmaniasis. The Scientific World JOURNAL. 2015(1). 414378–414378. 31 indexed citations
9.
Chakravarty, Jaya, Shyam Sundar, Ankita Chourasia, et al.. (2015). Outcome of patients on second line antiretroviral therapy under programmatic condition in India. BMC Infectious Diseases. 15(1). 517–517. 35 indexed citations
10.
Kumar, Dinesh, Puja Tiwary, Jaya Chakravarty, & Shyam Sundar. (2014). Association of Interleukin-18 Gene Polymorphism with Susceptibility to Visceral Leishmaniasis in Endemic Area of Bihar, an Indian Population. The Scientific World JOURNAL. 2014. 1–6. 13 indexed citations
11.
Pathak, Abhishek, et al.. (2014). A pilot study to evaluate the effect of HAART on gonadal dysfunction in male HIV patients. National Journal of Physiology Pharmacy and Pharmacology. 5(1). 33–33. 7 indexed citations
12.
Sundar, Shyam & Jaya Chakravarty. (2012). Leishmaniasis: an update of current pharmacotherapy. Expert Opinion on Pharmacotherapy. 14(1). 53–63. 193 indexed citations
13.
Sundar, Shyam, Prabhat Kumar Sinha, Madhukar Rai, et al.. (2011). Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial. The Lancet. 377(9764). 477–486. 239 indexed citations
14.
Kumar, Dinesh, et al.. (2011). A Novel 12.6-kDa Protein of Leishmania donovani for the Diagnosis of Indian Visceral Leishmaniasis. Vector-Borne and Zoonotic Diseases. 11(10). 1359–1364. 7 indexed citations
15.
Kumar, Dinesh, et al.. (2011). Identification and Characterization of a Novel, 37-Kilodalton Leishmania donovani Antigen for Diagnosis of Indian Visceral Leishmaniasis. Clinical and Vaccine Immunology. 18(5). 772–775. 10 indexed citations
16.
Agarwal, Dipti, et al.. (2010). Ultrasonography for diagnosis of abdominal tuberculosis in HIV infected people.. PubMed. 132. 77–80. 18 indexed citations
17.
Sundar, Shyam, Neha Agrawal, Rakesh Arora, et al.. (2009). Short‐Course Paromomycin Treatment of Visceral Leishmaniasis in India: 14‐Day vs 21‐Day Treatment. Clinical Infectious Diseases. 49(6). 914–918. 35 indexed citations
18.
Agarwal, Dipti, et al.. (2008). Correlation between clinical features and degree of immunosuppression in HIV infected children.. PubMed. 45(2). 140–3. 21 indexed citations
19.
Sundar, Shyam, P Olliaro, Jaya Chakravarty, et al.. (2007). Combination liposomal amphotericin B (AmBisome (R), AmB) and miltefosine (MF) for the treatment of visceral leishmaniasis (VL) in northern Bihar, India. American Journal of Tropical Medicine and Hygiene. 77. 109–109. 1 indexed citations
20.
Lahiri, Pulak, Jaya Chakravarty, & S. M. Sircar. (1990). Residue accumulation in mice chronically fed lindane (γ-HCH).. 56(3). 277–280.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026